ADMA Biologics
ADMA
ADMA
355 hedge funds and large institutions have $1.91B invested in ADMA Biologics in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 134 increasing their positions, 109 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.68% less ownership
Funds ownership: 92.62% → 88.94% (-3.7%)
52% less capital invested
Capital invested by funds: $4.02B → $1.91B (-$2.11B)
75% less funds holding in top 10
Funds holding in top 10: 8 → 2 (-6)
Holders
355
Holding in Top 10
2
Calls
$67.1M
Puts
$29.3M
Top Buyers
| 1 | +$71.9M | |
| 2 | +$67.7M | |
| 3 | +$45.7M | |
| 4 |
Millennium Management
New York
|
+$43.6M |
| 5 |
Jane Street
New York
|
+$40.9M |
Top Sellers
| 1 | -$207M | |
| 2 | -$128M | |
| 3 | -$121M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$60.6M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$57.3M |
